Abstract
“Autoinflammatory syndromes” is the broad name given to a group of heritable conditions that initially consisted of a group of diseases termed hereditary periodic fever syndromes. Autoinflammatory syndrome is the preferred name for these conditions, because not all of the disorders that have been added to this class of inflammatory disorde rs present with periodic febrile episodes. In contrast to autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, autoanti-bodies and antigen-specific T cells do not play a role in the pathogenesis of the autoinflammatory syndromes. Although the term autoinflammatory syndrome is now commonly used to include polygenic diseases such as Behcet's syndrome, Still's disease, and even Type 2 diabetes, this chapter addresses the monogenic autoin-flammatory syndromes. These syndromes demonstrate a Mendelian inheritance pattern, and their genetic causes have been identified. The disorders typically present in childhood. The disorders are divided into different clinical syndromes that include mixtures of clinical manifestations in the joints, the bones, the skin, the abdomen, and the lymph nodes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aganna E, Hammond L, Hawkins PN, et al Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 2003;48(9):2632– 44
Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20(3):319– 25
Aksentijevich I, Galon J, Soares M, et al The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001;69(2):301– 14
Aksentijevich I, Nowak M, Mallah M, et al De novo CIAS1 mutations, cytokine activation, and evidence for geneticheterogeneity in patients with neonatal-onset multisystem inflammatory disease. NOMID a new member of the expanding family of pyrin-associated autoin-flammatory diseases. Arthritis Rheum. 2002 46(12):3340Č“8
Aksentijevich I, Putnam C, Remmers EF, et al The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56(4): 1273– 85
Aksentijevich I, Torosyan Y, Samuels J, et al Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999;64(4):949– 62
Al-Mosawi ZS, Al-Saad KK, Ijadi-Maghsoodi R, et al A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum. 2007;56:960– 4
Altiparmak MR, Pamuk ON, Pamuk GE, et al Amyloid goitre in familial Mediterranean fever: report on three patients and review of the literature. Clin Rheumatol. 2002;21(6):497– 500
Ammouri W, Cuisset L, Rouaghe S, et al Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology. 2007;46(10):1597– 600
Arostegui JI, Solis P, Aldea A, et al Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response. Eur J Pediatr. 2005;164(1):13– 6
Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003;62(10):916– 9
Brik R, Litmanovitz D, Berkowitz D, et al Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain. J Pediatr.2001; 138:759–62
Cohen SL, Boner G, Shmueli D, et al Cyclosporin: poorly tolerated in familial Mediterranean fever. Nephrol Dial Transplant. 1989; 4(3):201– 4
Cortis E, DeBenedetti F, Insalaco A, Cioschi S, Muratori F, D' Urbano LE, Uqazio AG. Abnormal production of tumor necrosis factor (TNF) — alpha and clinical efficacy of the TNF inhibitor etan-ercept in a patient with PAPA syndrome [corrected]. J Pediatr. 2004;145(6): 851–5
Cuisset L, Drenth JP, Berthelot JM, et al Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet. 1999;65(4): 1054–9
Delorme N, Drouet M, Thibaudeau A, et al Urticaire au froid. Allergie Et Immunologie. 2002;34(7):255–8
Demirkaya E, Caglar MK, Waterham HR, et al A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol. 2007;26(10):1757–9
Dierselhuis MP, Frenkel J, Wulfraat NM, et al Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology. 2005;44: 406–8
D'Osualdo A, Ferlito F, Prigione I, et al Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis — pathogenetic and clinical implications. Arthritis Rheum. 2006;54(3):998–1008
D' Osualdo A, Picco P, Caroli F, et al MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever. Eur J Hum Genet. 2005;13(3): 314–20
Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore). 1994;73(3):133–44
Duffy CM, Lam PY, Ditchfield M, et al Chronic recurrent multifocal osteomyelitis: review of orthopaedic complications at maturity. J Pediatr Orthop. 2002;22:501–5
Eleftheriou G, Bacis G, Fiocchi R, et al Colchicine-induced toxicity in a heart transplant patient with chronic renal failure. Clin Toxicol (Phila). 2008;17:1–4
El-Shanti H, Majeed HA, El-Khateeb M. Familial mediterranean fever in Arabs. Lancet. 2006;367:1016–24
Ferguson PJ, Chen S, Tayeh MK, et al Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed Syndrome). J Med Genet. 2005;42:551–7
Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Immunol. 2007;19:492–8
Fradkin A, Yahav J, Zemer D, et al Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever. Isr J Med Sci. 1995;31:(10): 616–20
Galon J, Aksentijevich I, McDermott MF, et al TNF receptor-associated periodic syndromes (TRAPS): Mutations in TNFR1 and early experience with Etanercept therapy. Faseb Journal. 2000;14(6): A1150
Gattorno M, Tassi S, Carta S, et al Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleu-kin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 2007;56(9):3138–48
Gattorno M, Pelagatti MA, Meini A, et al Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum. 2008a;58(5):1516–20
Gattorno M, Sormani MP, D'Osualdo A, et al A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum. 2008b;58(6):1823–32
Girschick HJ, Krauspe R, Tschammler A, et al Chronic recurrent osteomyelitis with clavicular involvement in children: diagnostic value of different imaging techniques and therapy with non-steroidal anti-inflammatory drugs. Eur J Pediatr. 1998;157:28–33
Goldbach-Mansky R, Dailey NJ, Canna SW, et al Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006;355(6):581–92
Goldbach-Mansky R, Shroff SD, Wilson M, et al A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoin-flammatory syndrome. Arthritis Rheum. 2008;58(8):2432–42
Hawkins PN, Lachmann HJ, Aganna E, et al Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50(2):607–12
Hill SC, Namde M, Dwyer A, Poznanski A, et al Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA). Pediatr Radiol. 2007;37(2):145–52
Hoffman HM, Gregory SG, Mueller JL, Tresierras M, Broide DH, Wanderer AA, Kolodner RD. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet. 2003;112(2):209–216
Hoffman HM, Mueller JL, Broide DH, et al Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001a;29(3):301–5
Hoffman HM, Rosengren S, Boyle DL, et al Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364(9447): 1779–85
Hoffman HM, Throne ML, Amar NJ, et al Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 2008;58(8):2443–52
Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflamma-tory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001b;108(4):615–20
Hoffmann GF, Charpentier C, Mayatepek E, et al Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91(5):915–21
Houten SM, Kuis W, Duran M, et al Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nature Genetics. 1999;22(2):175–7
Huggins ML, Radford PM, McIntosh RS, et al Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum. 2004;50(8):2651–9
Hull KM, Drewe E, Aksentijevich I, et al The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflam-matory disorder. Medicine (Baltimore). 2002;81(5):349–68
Jacobelli S, Andre M, Alexandra JF, et al Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS). Rheumatology (Oxford). 2007;46(7):1211–2
Kallinich T, Haffner D, Niehues T, et al Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007;119(2):e474–83
Kallinich T, Haffner D, Rudolph B, et al “Periodic fever” without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptom-atic amyloidosis. Ann Rheum Dis. 2006;65(7):958–60
Kastner D. Familial Mediterranean fever. In: Fauci A, Braunwald E, Kasper D, Hauser SL, Longo DL, Jameson L, Loscalzo J, editors. Harrison' s principle of internal medicine. 17th ed. USA: McGraw-Hill; 2008
Kavukçu S, Türkmen M, Eroğlu Y, et al Renal, gastric and thyroidal amyloidosis due to familial Mediterranean fever. Pediatr Nephrol. 1997;11(2):210–2
Kilcline C, Shinkai K, Bree A, et al Neonatal-onset multisystem inflam-matory disorder: the emerging role of pyrin genes in autoinflamma-tory diseases. Arch Dermatol. 2005;141(2):248–53
Labro MT. Macrolide antibiotics: current and future uses. Expert Opin Pharmacother. 2004;5:541–50
Lachmann HJ, Sengul B, Yavuzsen TU, et al Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006;45:746–50
Leslie KS, Lachmann HJ, Bruning E, et al Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Arch Dermatol. 2006;142(12):1591–7
Majeed HA, Al-Tarawna M, El-Shanti H, et al The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. Eur J Pediatr. 2001;160:705–10
Majeed HA, El-Shanti H, Al-Rimawi H, et al On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia. J Pediatr. 2000;137:441–2
Majeed HA, Kalaawi M, Mohanty D, et al Congenital dyserythropoi-etic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr. 1989;115:730–4
McDermott MF, Aksentijevich I, Galon J, et al ermline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97(1):133–44
Mimouni A, Magal N, Stoffman N, et al Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amy-loidosis. Pediatrics. 2000;105(5):E70
Minetti EE, Minetti L. Multiple organ failure in a kidney transplant patient receiving both colchicine and cyclosporine. J Nephrol. 2003;16(3):421–5
Neittaanmäki H. Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol. 1985;13(4):636–44
Neven B, Callebaut I, Prieur AM, et al Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cellmediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2004;103(7):2809–15
Novack DV, Faccio R. Jawing about TNF: new hope for cherubism. Cell. 2007;128:15–7
Prieur AM, Griscelli C, Lampert F, et al A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol. 1987;66 Suppl:57–68
Prieur AM. A recently recognised chronic inflammatory disease of early onset characterized by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol. 2001;19(1): 103–6
Rynne M, Maclean C, Bybee A, et al Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann Rheum Dis. 2006;65:533–4
Saito M, Nishikomori R, Kambe N, Fujisawa A, Tanizaki H, et al Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-asso-ciated periodic syndrome patients. Blood. 2008;111(4):2132–41
Samuels J, Aksentijevich I, Torosyan Y, et al Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore). 1998;77(4):268–97
Sato TS, Khanna G, Ferguson PJ. Primary multifocal osseous lymphoma in a child. Pediatr Radiol. 2008;38:1338–41
Schilling F, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifcal osteomyelitis? A preliminary report. Z Rheumatol. 2000;59:352–3
Shinkai K, McCalmont TH, Leslie KS. Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol. 2008;33(1): 1–9
Shoham NG, Centola M, Mansfield E, et al Pyrin binds the PSTPIP1/ CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A.. 2003;100(23):13501–6
Siewert R, Ferber J, Horstmann RD, et al Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis. 2006;48(3):e41–5
Simon A, Bodar EJ, van der Hilst JC, et al Beneficial response to inter-leukin 1 receptor antagonist in TRAPS. Am J Med. 2004a;117(3): 208–10
Simon A, Kremer HP, Wevers RA, et al Mevalonate kinase deficiency: Evidence for a phenotypic continuum. Neurol. 2004b;62(6):994–7
Speeg K V, Maldonado AL, Liaci J, et al Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo. J Pharmacol Exp Ther. 1992;261(1):50–5
Stankovic K, Grateau G. Auto inflammatory syndromes: Diagnosis and treatment. Joint Bone Spine. 2007;74:544–50
Stichweh DS, Punaro M, Pascual V. Dramtic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol. 2005;22(3):262–5
Stoffman N, Magal N, Shohat T, et al Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000;8(4):307–10
Stojanov S, Kastner DL. Familial autoinflammatory diseases: Genetics, pathogenesis and treatment. Curr Opin Rheumatol. 2005;17(5): 586–99
Tallon B, Corkill M. Peculiarities of PAPA syndrome. Rheumatology. 2006;45:1140–3
The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17(1):25–31
The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807
Thornton BD, Hoffman HM, Bhat A, Don BR. Am J Kidney Dis. 2007;49:477–81
Touitou I, Sarkisian T, Medlej-Hashim M, et al Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56(5):1706–12
Ueki Y, Lin CY, Senoo M, et al Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 “cherubism” mice. Cell. 2007;128:71–83
Ueki Y, Tiziani V, Santanna C, et al Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28:125–6
van der Hilst J, Bodar E, Barron K, et al Follow-up, clinical features, and quality of life in 10.3 patients with HyperImmunoglubulin D syndrome. Clin Exp Rheumatol. 2008;26(2):180
van der Meer JW, Vossen JM, Radl J, et al Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984;1(8386): 1087–90
Williamson LM, Hull D, Mehta R, et al Familial Hibernian fever. Q J Med. 1982;1(204):469–80
Yamazaki T, Masumoto J, Agematsu K, et al Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome,possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum. 2008;58(3):864–8
Yarom A, Rennebohm RM, Levinson JE. Infantile multisystem inflam-matory disease: a specific syndrome? J Pediatr. 1985;106(3): 390–6
Yildiz A, Akkaya V, Kiliçaslan I, et al Cardiac and intestinal amyloido-sis in a renal transplant recipient with familial Mediterranean fever. J Nephrol. 2001;14(2):125–7
Yu JW, Fernandes-Alnemri T, Datta P, et al Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol Cell. 2007;28:214–227
Meng XM et al. Clinicopathologic study of 24 cases of cherubism. Int J Oral Maxillofac Surg. 2005;34:350–6
Jain V, Sharma R. Radiographic, CT and MRI features of cherubism. Pediatr Radiol. 2006;36(10):1099–104
Acknowledgment
We would like to thank Dr. Daniel Kastner for sharing his expertise and suggestions for the myths and pearls in the FMF section.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Gattorno, M., Martini, A., Goldbach-Mansky, R., Aubert, P., Ferguson, P.J. (2009). Monogenic Autoinflammatory Syndromes. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-84800-934-9_5
Publisher Name: Springer, London
Print ISBN: 978-1-84800-933-2
Online ISBN: 978-1-84800-934-9
eBook Packages: MedicineMedicine (R0)